BCYC logo

Bicycle Therapeutics plc American Depositary Shares


BCYC: Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.


Show BCYC Financials

Consumer Interest
SEC Filings

Recent trades of BCYC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BCYC's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods and compositions Jun. 06, 2017
  • Patent Title: Multispecific peptides Jun. 06, 2017
  • Patent Title: Connector compound peptide phage display May. 23, 2017
  • Patent Title: Structured peptide processing May. 09, 2017
  • Patent Title: Peptide libraries Dec. 13, 2016
  • Patent Title: Structured peptide processing Jul. 15, 2014
  • Patent Title: Multispecific peptides Apr. 01, 2014
  • Patent Title: Methods and compositions Mar. 25, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BCYC in WallStreetBets Daily Discussion


Recent insights relating to BCYC

CNBC Recommendations

Recent picks made for BCYC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BCYC

Corporate Flights

Flights by private jets registered to BCYC